Meeting
2022 ASCO Gastrointestinal Cancers Symposium
A prospective trial to evaluate the performance of the multitarget hepatocellular carcinoma blood test (mt-HBT) for screening at-risk patients: The Altus study.
Authors
Binu John
University of Miami, Miami, FL
Binu John , Kyle Porter , Bassam Dahman , Neehar Parikh , Alvin C. Silva , Ju Dong Yang , Patrick Joseph , Laura E. Strong , Paul J. Limburg
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Prevention, Screening, and Hereditary Cancers
Clinical Trial Registration Number
NCT05064553
DOI
10.1200/JCO.2022.40.4_suppl.TPS486
Abstract #
TPS486
Poster Bd #
N5
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Prostate screening for men with inherited risk of developing aggressive prostate cancer: The PATROL study.
First Author: Heather H. Cheng
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Multi-target blood test to improve the performance of hepatocellular carcinoma surveillance programs: A modeling-based virtual trial.
First Author: Jagpreet Chhatwal
Poster
2021 ASCO Annual Meeting
Comparing the clinical impact of pancreatic cyst surveillance programs: A trial of the ECOG-ACRIN cancer research group (EA2185).
First Author: David Weinberg
Poster
2021 Gastrointestinal Cancers Symposium
Development and clinical validation of a blood test for early detection of colorectal adenomas and cancer.
First Author: Shai Friedland